© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Bacterial infections used to be bleak business before scientists unlocked the power of sulfonamides in the 1930s. Sulfamerazine Sodium, a blend of chemistry and human curiosity, rose to attention during the era when people sought alternatives to penicillin. German chemists worked tirelessly in labs, and soon, this compound helped shape an age when some infections finally had a formidable rival. Its story mirrors the grit and resourcefulness of researchers who often worked without the modern safety gear or protocols people now take for granted, yet brought therapeutic breakthroughs. Hospitals saw real, measurable drops in mortality rates—not through solitary miracles, but through collective commitment stretching across borders and decades.
Sulfamerazine Sodium, a white or faintly yellowish powder, stands out as an antimicrobial heavy hitter in the sulfonamide family. Developed initially for oral and injectable routes, it’s been packaged in tablets, bulk powder, and sterile solutions for decades. The compound carries the signature ability to disrupt folic acid metabolism in sensitive bacteria—a mechanism that future generations of synthetic antibiotics have adapted or outright copied. In dusty field clinics and polished urban hospitals, it supported physicians dealing with everything from wound sepsis to pneumonia. Its shelf life, usually two to three years under proper conditions, reflects solid chemical stability that many generic versions still strive to replicate.
In terms of structure, Sulfamerazine Sodium boasts a crystalline powder form, running soluble in water yet less eager to blend into organic solvents like ethanol. That trait shapes how pharmacists reconstitute it for injection or suspension. The sodium salt increases the compound’s water compatibility, translating to quicker absorption and less irritation upon administration. The melting point hovers near 220°C, chalking up another point for thermal resilience. Color can shift slightly over time, but impurities tend to manifest as clumping or odd discoloration, so most suppliers run purity checks over 98%. The molecule weighs in at just over 278 daltons, sitting comfortably in a range suitable for systemic antimicrobial action without unnecessary molecular baggage.
Drug regulators demand tight accuracy. A label bearing Sulfamerazine Sodium will show its batch number, exact mass, chemical name, manufacturer, and expiry date. Dosing instructions steer prescribers to 25–50 mg/kg patient body weight, often split over several administrations. In human medicine, the US Pharmacopeia (USP) and European Pharmacopoeia (EP) dictate assay limits and acceptable impurity levels, often capping any single impurity below 0.5%. Some veterinary formulations list withdrawal times for edible tissues, as farmers need those figures for compliance. Labels must warn about sulfa allergies and possible cross-reactions with related agents.
Making Sulfamerazine Sodium isn’t for the faint of heart or the backyard chemist. Most preparation routes start with sulfanilamide and an aromatic aldehyde to introduce the necessary side chain. Controlled condensation and sulfonation occur under cooled, slightly alkaline conditions, keeping side reactions minimal. Sodium hydroxide or another mild base then neutralizes the final product, yielding the sought-after sodium salt. The process demands solid control over temperature and pH, or unexpected byproducts crop up and complicate purification. Industrial engineers lean on continuous monitoring and closed systems not simply for efficiency, but for cleaner, reproducible yields batch after batch.
Once synthesized, modification expands Sulfamerazine Sodium’s profile. Chemists tweak attached groups to dial in solubility, duration, or specificity. Certain derivatives perform better against stubborn pathogens, while others boost excretion rates to minimize toxicity. Sulfonamides famously form crystal complexes, meaning solution pH and counterions impact precipitation risk. Some labs investigate conjugating Sulfamerazine Sodium to biodegradable carriers, chasing extended-release possibilities without dosing spikes. Given sulfonamides’ broad core, ongoing research in modifying the amine ring or aromatic structure still pops up in academic journals, reflecting both challenge and opportunity.
The world’s regulatory systems forced this molecule to find many aliases. Some know it as Sodium N-(4-methyl-2-pyrimidinyl)sulfanilamidate, others run into older labels such as Sulfamerazin Natrium. You’ll spot product names like Sulfadine Sodium in livestock catalogs or Merazine Sodium in generic drug directories. Medical staff sometimes use short-hand, calling it just “sulfa sodium” or “sulfa-MZ” in wards. Pharmacists track these names to avoid dosing mistakes, especially since look-alike, sound-alike drugs can slip into busy workflows. Synonyms matter not out of trivia, but out of safety and clarity—a lesson that stands out when two drugs with similar names sit side-by-side in a storeroom.
Those who mix, pack, or administer Sulfamerazine Sodium face clear safety rules. Exposure to sulfonamides can trigger allergic reactions, from mild rash to full-blown anaphylaxis, so gloves and protective eyewear are standard gear in manufacturing plants. Hospitals audit handling protocols, making sure spills get managed by staff with specialized training, not just mopped up carelessly. Veterinary settings guard against accidental overdosing, since feed mixing mistakes risk both animal health and consumer trust once contaminated products reach market shelves. Storage rooms keep the powder cool, dry, and far from sunlight since moisture can spark degradation—though the compound keeps its punch if workers stick to those rules.
Doctors first reached for Sulfamerazine Sodium to fight pneumonia, meningitis, and wound infections—long before modern cephalosporins or fluoroquinolones arrived. Its use drifted into veterinary spheres as demand rose for affordable treatments in cattle, swine, and poultry. Feedlot operators often rely on water-soluble powder to stave off outbreaks in crowded pens, though such practices demand rigid withdrawal periods before harvest. In research, Sulfamerazine Sodium enjoys a quiet afterlife as a model inhibitor in enzymatic studies, helping bench scientists probe folate metabolism or antibiotic resistance pathways. Modern hospitals rarely list it as the top-line drug, but the molecule maintains a loyal following for certain infections when newer options fail or allergies limit choices.
Decades of investigation taught the medical field both the promise and the pitfalls of Sulfamerazine Sodium. Biologists still publish on drug-resistant strains, noting how plasmid-encoded enzymes or efflux pumps blunt this drug’s effect. Medicinal chemists sift through modifications, searching for tweaks that keep up with evolving bacteria. A handful of startup labs have explored nanoparticle carriers to boost tissue penetration or stagger drug release, seeking the best balance between sustained effect and patient comfort. Epidemiologists compile usage and resistance data, field-testing protocols in rural clinics just as thoroughly as in city centers where policies shift with emerging outbreaks. The steady march of research protects public health by keeping proven drugs on the radar—helping health workers avoid disaster if a new plague catches modern medicine off guard.
Toxicologists track Sulfamerazine Sodium’s downsides with the vigilance earned from past harm. Sulfonamide-induced hypersensitivity ranks among the chief worries, with symptoms spanning from mild fevers to life-threatening Stevens-Johnson syndrome. Labs document blood abnormalities like agranulocytosis or hemolytic anemia in vulnerable people, especially those with certain genetic markers. Animal studies highlighted risks like crystal formation in the urinary tract, pushing clinicians to stress hydration and monitor kidney function during lengthy courses. Toxicity data drives modern dose recommendations and patient screening, anchoring guidelines in facts rather than guesswork. Communicating these risks clearly, both on the label and at the bedside, forms the backbone of responsible medicinal chemistry.
Skeptics might count Sulfamerazine Sodium among sunset drugs, but careful eyes notice a resurgence in antibiotic innovation that values old chemistry made new. Drug combinations, supportive therapies, and personalized dosing strategies breathe new life into established molecules. As antimicrobial resistance rises worldwide, governments and nonprofit coalitions revisit older agents for cost-effective control of infections in low-resource settings. Modern formulation science, including liposomal delivery or prodrug manipulation, nudges this compound into fresh clinical trials and veterinary studies. Regulatory demands for environmental stewardship now spur researchers to investigate biodegradable derivatives or more responsible waste management in factories. In the end, Sulfamerazine Sodium’s journey continues, guided by equal measures of caution and hope—qualities that define medicine at its best.
Sulfamerazine sodium shows up as a tried-and-true member of the sulfonamide group. Doctors and veterinarians have turned to it for decades, mostly to fight off bacterial infections in animals. In a world awash with modern medicine, older antibiotics like this still hold a place, especially when dealing with livestock—cattle, pigs, poultry—who make up the backbone of so many farming communities. In these settings, animals face a constant barrage of bacteria in their skin, respiratory tract, or digestive system. Quick action matters; sick animals hurt the farm’s bottom line and put food chains at risk.
For my own background, growing up around small family farms taught me lessons about what happens when infections spread unchecked. A single case of shipping fever in calves can turn into a bigger outbreak overnight. Sulfamerazine sodium steps in for specific infections like pneumonia, foot rot, or even bacterial diarrhea. It delivers results without needing the powerful, broad-spectrum antibiotics reserved for more severe threats. Using it as directed keeps resistance in check, which has become a central worry around the world.
Sulfamerazine sodium attacks by interfering with an enzyme pathway that bacteria use to make folic acid—a vitamin they need to survive. This weakens the bacteria and gives the animal’s immune system the time needed to finish the job. The mechanism isn’t flashy, but reliability counts. Only some bacteria, mainly gram-positive strains and certain gram-negatives, fall under its umbrella. That means it gets used with care and only with vets’ guidance.
The biggest red flag with old-school drugs like this centers on resistance. Bacteria evolve, especially when people skip dosages or don’t finish the prescribed course. Farmers can fall into the trap of overusing these antibiotics as a quick fix. The CDC and World Health Organization sound warning bells about resistance transferring from animals to humans. Studies show repeated use in livestock, even at low levels, helps bacteria adapt, so drugs lose their punch.
Across places like the US, Canada, and Europe, strict oversight exists to keep things under control. Sulfamerazine sodium requires a prescription from licensed veterinarians. There are withdrawal times: farmers need to stop giving the medication well ahead of slaughter or when collecting milk. Random batch sampling at dairy plants and slaughterhouses helps catch violations. Regulators catch up with bad actors, fining or barring them from selling products. This helps keep meat, eggs, and milk safe for the public.
The answer isn’t ditching older antibiotics. Instead, better education and attention to animal welfare push things forward. Farmers work with their vets to diagnose infections, use precise dosages, and monitor changes. Alternatives like vaccines, good hygiene, and selective breeding for disease resistance play a growing role in keeping infections at bay. One positive example I saw was a neighbor who only used Sulfamerazine sodium by prescription, tracked every treatment, and relied more on clean bedding and less crowded pens. Healthy flocks, less worry about resistant germs—that’s the goal.
Anyone who works around livestock or veterinary care hears about sulfa drugs like Sulfamerazine Sodium. It’s a go-to antibiotic for a range of bacterial infections, especially in large animals such as cattle and poultry. As someone who grew up helping out on a dairy farm, I’ve watched veterinarians stress clarity and accuracy when using antibiotics, because every animal’s health—and the safety of the food chain—rests on getting it right.
The most common place you’ll see recommendations is in veterinarian manuals or product labels, because the right dose depends on both species and illness severity. For cattle or poultry, Sulfamerazine Sodium is usually given at a rate of around 50 to 100 mg per kilogram of body weight per day. That gets divided up over two to three doses. In practice, the exact amount can change based on whether you’re dealing with shipping fever, fowl cholera, or something less severe. A veterinarian has to weigh the animal—sometimes literally with a scale, sometimes just an educated guess for herd treatments—and calculate down to the kilo.
There’s a danger in improvising doses. Giving too much of any antibiotic leads to resistance, which has become a real problem in both agriculture and human medicine. A study from the Centers for Disease Control and Prevention highlights how antibiotic misuse in animals contributes to resistance that filters through meat and milk back to people. Giving too little, on the flip side, won’t clear up an infection and might even drive resistant bacteria to thrive. Responsible dosing means the difference between a quick recovery and a stubborn outbreak, which hits a farmer in the wallet and can make you question food safety down the line.
Beyond picking the right dose, people get caught when they ignore withdrawal times. After treatment with Sulfamerazine Sodium, animals need a certain period to clear the drug from their system. For cattle, withdrawal typically sits around 10 to 14 days, while poultry ranges from five to ten days depending on local regulations. The Food and Drug Administration monitors these timelines closely. Failing to follow them can get producers in trouble; I’ve seen milk tanks dumped entirely or flocks held from market when someone got sloppy or mixed up dosage records.
Most veterinarians rely on the Merck Veterinary Manual, FDA Green Book, and support from animal health companies when calculating the right dose. In the age of digital records, keeping accurate logs has gotten easier. Yet, mistakes still happen. My neighbor once treated a dozen calves during a hectic season and lost track of their start and end dates—only to face a costly delay selling them because he had no written record.
More producers now use dosing calculators or mobile apps that automate calculations based on animal weight and species. Support from extension offices and ongoing education has made a visible difference. I’ve learned firsthand that taking the time to double-check calculations, write down every treatment, and talk openly with the vet shields both animal health and consumer trust. Each dose counts—up close on the farm, and all the way downstream to dinner plates everywhere.
Sulfamerazine Sodium lands on the list of sulfonamide antibiotics. It’s found its primary use in fighting bacterial infections, especially in livestock. People who handle animals, or work in agriculture, run into these drugs often. I’ve seen many ranchers and veterinarians keep an eye on how their animals respond every time they add this compound to a treatment plan. Just like other antibiotics, it doesn’t come without its risks.
The most common problems start with allergic reactions. People with allergies to sulfa drugs can break out in hives, develop trouble breathing, or even notice swelling in their faces or throats. Healthcare professionals urge anyone with a history of sulfa allergies to avoid this medicine. Even those with no known allergies should observe closely for warning signs. Immediate medical help is key for any swelling or breathing issues.
Digestive systems seem to take a hit too. Nausea, vomiting, and loss of appetite show up quite often. Diarrhea can follow. These don’t just feel uncomfortable—they can sap energy and leave a person dehydrated. Some cases call for stopping the drug if the symptoms turn severe. In rare runs, some folks develop serious gut inflammation called pseudomembranous colitis, usually traced to a shift in gut bacteria and a spike in harmful strains like Clostridioides difficile.
On a broader scale, sulfonamides can hurt blood cell production. I’ve heard about and read case reports describing anemia, low white cell counts, and even low platelets causing bruising or dangerous infections. Most of those come from longer stints on the drug, but once someone notices easy bruising or gets frequent infections, they have to let their provider know. Blood tests monitor these issues best.
This drug doesn’t stop at just hurting white cells. It can put extra pressure on the kidneys, especially in patients who already have weak kidney function. Some people get crystals that block the urine flow or set off pain in the lower back. Staying hydrated makes a difference. Most doctors say that drinking water throughout the day can cut down the risk for kidney stones and crystal formation.
Liver troubles round out the major side effects. Jaundice, or a yellow tint to skin and eyes, may signal trouble brewing inside the liver. Abnormal liver labs pop up sometimes, too. It pays to monitor for dark urine, pale stools, or abdominal pain and to report them right away.
Tough as these side effects sound, the answer often rests in smart monitoring. Health professionals track blood counts and kidney markers. They stress the importance of telling patients about possible allergies. If any allergic reactions or digestion problems happen, stopping the drug early keeps serious problems from snowballing.
Building solid communication among patients, veterinarians, doctors, and pharmacists lays the foundation for safe use. Resources such as the FDA website and peer-reviewed clinical reports keep everyone in the loop about risks and help catch issues early. Labs, honest dialogue, and an alert for early warning signs all cut down the dangers.
Sulfamerazine sodium has earned a place in veterinary shelves and lab discussions for years. As someone with a background in both animal health and community pharmacy, I’ve seen the interest spark up whenever people notice its name in treatment protocols. Farmers looking to protect their herds and folks reading their pet’s antibiotic labels want to know what it actually does, who can take it, and how safe it really is, especially as the lines between veterinary and human medicine sometimes blur.
This medication belongs to the sulfonamide class—one of the oldest groups of antibiotics. It targets certain bacteria by blocking their ability to produce folic acid, something they need to survive. In animals, especially cattle and poultry, sulfamerazine sodium often enters the conversation during outbreaks of respiratory or gastrointestinal infections. Once, I watched a local poultry farm bounce back from a tough stretch using this approach, under the clear direction of a licensed vet. In those cases, the goal was always control: treat the infection, avoid suffering, and limit the spread within close quarters.
The veterinary side sees a fair bit of value. With food-producing animals, withdrawal periods before slaughter or collection of animal products like milk always become part of the decision-making. Regulators and producers both want to keep drug residues away from the dinner plate. Labeling rules spell out the necessary waiting times. Owners need regular guidance and veterinarians often stress the importance of not mixing up withdrawal times with those for other medicines. A missed step here could mean contaminated food, economic losses, or even big legal trouble for farms.
Decades ago, doctors sometimes reached for sulfamerazine sodium to treat urinary tract infections, meningitis, or other bacterial threats in human patients. Today, the story has changed a lot. Resistance crept in over time—bacteria adapted, and newer drugs stepped up, pushing many of these older sulfonamides to the sidelines. A walk through a modern hospital pharmacy rarely turns up a prescription for it. Instead, most providers prefer more targeted or safer alternatives, particularly since allergies and side effects once linked to sulfa drugs aren’t rarely seen.
No one likes the idea of contributing to the spread of antibiotic resistance. Misuse pushes bacteria to become tougher, making even common infections harder to treat in the long run. Authorities like the FDA and CDC warn against self-medicating with antibiotics approved for veterinary use, pointing out serious safety concerns. Dosage differences, risk of toxicity, or even product impurities mean mistakes can have serious, sometimes deadly consequences.
Access to accurate information has never mattered more. Both pet owners and livestock producers can avoid risky shortcuts by keeping open lines with veterinary and medical professionals. Doctors have moved away from using older antibiotics like sulfamerazine sodium unless absolutely necessary, often due to proven resistance or the availability of better alternatives. Experts also stress the need for responsible prescribing—choosing the right medication only after confirming the source of the infection.
Addressing the challenge means investing in better diagnostics, updating treatment guidelines, and continuing education for healthcare workers. Those efforts help make sure antibiotics—old or new—remain effective tools instead of blunt instruments. Every health decision involving medications like sulfamerazine sodium connects back to a simple idea: careful, shared stewardship over the tools that protect lives, animal and human alike. By respecting guidelines and trusting professional advice, communities can push back against resistance and protect public health, one smart choice at a time.
Sulfamerazine sodium works as a sulfonamide antibiotic, often used in veterinary and research contexts. Data from the World Health Organization highlight that deteriorated pharmaceuticals pose health risks not only due to loss of effectiveness but also due to formation of toxic degradation products. My years in a laboratory setting remind me: cutting corners on storage often leads to wasted product and unnecessary expense. By giving attention to storage technique, the risk of having to throw out expensive materials or endangering animal health shrinks rapidly.
Real-world experience has shown that this compound handles best in cool, dry environments. The USP suggests a range between 15°C and 30°C, so aim for room temperature, away from direct heat. Exposure to humidity or excessive warmth often leads to clumping or visible discoloration. Just last year, I watched a research team scrap a whole batch due to powder gone yellow after exposure to moisture from a leaking air conditioner. Paying attention to environmental controls saves that kind of headache.
Sunlight and room lighting take a real toll on sulfamerazine sodium. Photosensitivity can set off a chemical breakdown. Sealed amber glass keeps the product serviceable for far longer than clear packaging or open storage. In a pharmacy setting I once worked in, loss from using the wrong containers added up to hundreds of dollars per quarter—a fixable problem with centered guidelines on storage.
That same pharmacy switched to airtight, light-blocking jars, making sure the cap felt tight each time after use. We saw a drop in wastage and hard evidence for the importance of good packaging.
Even the most careful storage can’t compensate for poor labeling. Dates and batch numbers need to be clear, so tracking shelf life stays simple. In clinics I’ve visited, confusion about batch expiry led to treatments slipping through with degraded material. Patients and animals depend on safe product, so clarity helps avoid accidental usage past the prime window.
Cross-contamination between different powdered drugs often occurs through shared scoops or workspace clutter. Tools and surfaces should stay clean, and hands washed before and after handling. I once saw a training session where two antibiotics, stored side by side, ended up mixed because someone reused a measuring spoon. Keeping each drug in its own labeled container, away from others, prevents that kind of mistake and keeps dose consistency on point.
Safe storage does more than maintain chemical stability. In healthcare or lab settings, security matters—an unlocked supply room invites unauthorized use or accidental exposure. Lockable cabinets or restricted-access storerooms work well, especially where untrained staff might mistake the product for something else.
Knowledge, training, and consistent follow-through all support safe handling. Compounds like sulfamerazine sodium deserve attention: the right environment, airtight containers, clear labeling, and routine checks all add up to safer research projects and livestock care.
| Names | |
| Preferred IUPAC name | sodium 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamidide |
| Other names |
Sodium sulfamerazine Sulfamerazine sodium salt Sulfamerazin-sodium Sulfonamethylpyrimidine sodium Sodium 4-amino-N-(4,6-dimethyl-2-pyrimidinyl)benzenesulfonamide |
| Pronunciation | /ˌsʌl.fə.məˈræz.iːn ˈsəʊ.di.əm/ |
| Identifiers | |
| CAS Number | 1981-87-1 |
| 3D model (JSmol) | `[NH2]c1nc(N)cc(S(=O)(=O)ONa)c1` |
| Beilstein Reference | 3204672 |
| ChEBI | CHEBI:31624 |
| ChEMBL | CHEMBL2104605 |
| ChemSpider | 14274 |
| DrugBank | DB00362 |
| ECHA InfoCard | 13f66cdf-a00d-4464-ab38-adfeab4b3068 |
| EC Number | 242-682-0 |
| Gmelin Reference | 83340 |
| KEGG | D01242 |
| MeSH | D013444 |
| PubChem CID | 25145 |
| RTECS number | WO8925000 |
| UNII | 6H25P1PB1Q |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C11H11N4NaO2S |
| Molar mass | 300.32 g/mol |
| Appearance | white or almost white crystalline powder |
| Odor | Odorless |
| Density | Density: 1.41 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -0.7 |
| Acidity (pKa) | 7.4 |
| Basicity (pKb) | pKb 7.1 |
| Magnetic susceptibility (χ) | -41.5e-6 cm³/mol |
| Dipole moment | 3.54 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 385.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01EB03 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory tract irritation. Harmful if swallowed. May cause allergic skin reaction. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | P264, P270, P273, P301+P312, P330, P501 |
| Explosive limits | Not explosive |
| Lethal dose or concentration | LD50 oral rat 10 g/kg |
| LD50 (median dose) | 6.5 g/kg (rat, oral) |
| NIOSH | RN:1981-58-4 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | '500 mg' |
| Related compounds | |
| Related compounds |
Sulfadimidine Sulfadiazine Sulfamerazine Sulfanilamide |
